Literature DB >> 25228014

Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study.

Eleonora Tavazzi1, Maria Marcella Laganà, Niels Bergsland, Paola Tortorella, Giovanna Pinardi, Christian Lunetta, Massimo Corbo, Marco Rovaris.   

Abstract

Primary progressive multiple sclerosis (PPMS) and amyotrophic lateral sclerosis (ALS) seem to share some clinical and pathological features. MRI studies revealed the presence of grey matter (GM) atrophy in both diseases, but no comparative data are available. The objective was to compare the regional patterns of GM tissue loss in PPMS and ALS with voxel-based morphometry (VBM). Eighteen PPMS patients, 20 ALS patients, and 31 healthy controls (HC) were studied with a 1.5 Tesla scanner. VBM was performed to assess volumetric GM differences with age and sex as covariates. Threshold-free cluster enhancement analysis was used to obtain significant clusters. Group comparisons were tested with family-wise error correction for multiple comparisons (p < 0.05) except for HC versus MND which was tested at a level of p < 0.001 uncorrected and a cluster threshold of 20 contiguous voxels. Compared to HC, ALS patients showed GM tissue reduction in selected frontal and temporal areas, while PPMS patients showed a widespread bilateral GM volume decrease, involving both deep and cortical regions. Compared to ALS, PPMS patients showed tissue volume reductions in both deep and cortical GM areas. This preliminary study confirms that PPMS is characterized by a more diffuse cortical and subcortical GM atrophy than ALS and that, in the latter condition, brain damage is present outside the motor system. These results suggest that PPMS and ALS may share pathological features leading to GM tissue loss.

Entities:  

Mesh:

Year:  2014        PMID: 25228014     DOI: 10.1007/s10072-014-1954-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  34 in total

Review 1.  Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis.

Authors:  Alan Thompson
Journal:  Mult Scler       Date:  2004-06       Impact factor: 6.312

2.  A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes.

Authors:  Antonia Ceccarelli; Maria A Rocca; Elisabetta Pagani; Bruno Colombo; Vittorio Martinelli; Giancarlo Comi; Massimo Filippi
Journal:  Neuroimage       Date:  2008-04-20       Impact factor: 6.556

3.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data.

Authors:  J G Sled; A P Zijdenbos; A C Evans
Journal:  IEEE Trans Med Imaging       Date:  1998-02       Impact factor: 10.048

4.  Amyotrophic lateral sclerosis is not linked to multiple sclerosis in a population based study.

Authors:  Perry T C van Doormaal; Alessandro Gallo; Wouter van Rheenen; Jan H Veldink; Michael A van Es; Leonard H van den Berg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-04-17       Impact factor: 10.154

5.  Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability.

Authors:  F Agosta; E Pagani; M A Rocca; D Caputo; M Perini; F Salvi; A Prelle; M Filippi
Journal:  Hum Brain Mapp       Date:  2007-12       Impact factor: 5.038

6.  Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis.

Authors:  Esther Verstraete; Jan H Veldink; Jeroen Hendrikse; H Jurgen Schelhaas; Martijn P van den Heuvel; Leonard H van den Berg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-09-29       Impact factor: 10.154

7.  Evaluating and reducing the impact of white matter lesions on brain volume measurements.

Authors:  Marco Battaglini; Mark Jenkinson; Nicola De Stefano
Journal:  Hum Brain Mapp       Date:  2011-08-31       Impact factor: 5.038

8.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

9.  Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis.

Authors:  Lawrence M Agius
Journal:  Patholog Res Int       Date:  2012-12-04

10.  Mapping cortical degeneration in ALS with magnetization transfer ratio and voxel-based morphometry.

Authors:  Mirco Cosottini; Paolo Cecchi; Selina Piazza; Ilaria Pesaresi; Serena Fabbri; Stefano Diciotti; Mario Mascalchi; Gabriele Siciliano; Ubaldo Bonuccelli
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more
  9 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

Review 2.  Therapeutic potential of curcumin for multiple sclerosis.

Authors:  Munibah Qureshi; Ebtesam A Al-Suhaimi; Fazli Wahid; Omer Shehzad; Adeeb Shehzad
Journal:  Neurol Sci       Date:  2017-10-27       Impact factor: 3.307

Review 3.  Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis.

Authors:  Yuan Cao; Wei Diao; Fangfang Tian; Feifei Zhang; Laichang He; Xipeng Long; Fuqinq Zhou; Zhiyun Jia
Journal:  Neuropsychol Rev       Date:  2021-02-13       Impact factor: 7.444

4.  Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis.

Authors:  M-S Buhour; F Doidy; A Mondou; A Pélerin; L Carluer; F Eustache; F Viader; B Desgranges
Journal:  EJNMMI Res       Date:  2017-03-06       Impact factor: 3.138

5.  Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis.

Authors:  Francisco Carlos Pérez-Miralles; Daniel Prefasi; Antonio García-Merino; José Ramón Ara; Guillermo Izquierdo; Virginia Meca-Lallana; Francisco Gascón-Giménez; María Luisa Martínez-Ginés; Lluis Ramió-Torrentà; Lucienne Costa-Frossard; Óscar Fernández; Sara Moreno-García; Jorge Maurino; Joan Carreres-Polo; Bonaventura Casanova
Journal:  Brain Behav       Date:  2021-01-23       Impact factor: 2.708

6.  Classification of amyotrophic lateral sclerosis by brain volume, connectivity, and network dynamics.

Authors:  Janine Thome; Robert Steinbach; Julian Grosskreutz; Daniel Durstewitz; Georgia Koppe
Journal:  Hum Brain Mapp       Date:  2021-10-16       Impact factor: 5.038

7.  Voxel-Wise Meta-Analysis of Gray Matter Changes in Amyotrophic Lateral Sclerosis.

Authors:  Dongchao Shen; Liying Cui; Jia Fang; Bo Cui; Dawei Li; Hongfei Tai
Journal:  Front Aging Neurosci       Date:  2016-03-30       Impact factor: 5.750

8.  A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation procedures.

Authors:  Alfredo Revenaz; Massimiliano Ruggeri; Marcella Laganà; Niels Bergsland; Elisabetta Groppo; Marco Rovaris; Enrico Fainardi
Journal:  BMC Med Imaging       Date:  2016-01-14       Impact factor: 1.930

9.  Combinatory Biomarker Use of Cortical Thickness, MUNIX, and ALSFRS-R at Baseline and in Longitudinal Courses of Individual Patients With Amyotrophic Lateral Sclerosis.

Authors:  Anna M Wirth; Andrei Khomenko; Dobri Baldaranov; Ines Kobor; Ohnmar Hsam; Thomas Grimm; Siw Johannesen; Tim-Henrik Bruun; Wilhelm Schulte-Mattler; Mark W Greenlee; Ulrich Bogdahn
Journal:  Front Neurol       Date:  2018-07-30       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.